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Abstract
Objective:  To  analyze  toll-like  receptor  (TLR)-2  and  TLR-4  expression  in  monocytes  of  newborns
with late-onset  sepsis.
Methods: This  prospective  study  included  27  full-term  newborns  aged  8  to  29  days,  with  clin-
ical and  laboratory  diagnosis  of  late-onset  sepsis.  Ten  newborns  (37%)  had  positive  cultures.
Cytokines  were  measured  by  cytometric  bead  array  in  peripheral  blood,  while  TLR-2,  TLR-4
expression,  and  median  ﬂuorescence  intensity  (MFI)  were  determined  by  immunophenotyp-
ing peripheral  whole  blood  monocytes,  and  were  analyzed  with  a  BD  FACSDiva  ﬂow  cytometer
(Becton, Dickinson  and  Company,  USA).  A  comparison  was  performed  with  healthy  adults.
Results:  Microorganisms  were  identiﬁed  in  37%  of  these  septic  newborns,  and  all  of  them  had
high  levels  of  pro-inﬂammatory  cytokines  (IL-8,  IL-6,  IL-1)  and  anti-inﬂammatory  cytokine
(IL-10)  corroborating  the  inﬂammatory/septic  process.  In  monocytes,  the  frequency  of  TLR-4
expression  was  higher  in  infected  newborns  (p  =  0.01).
Conclusion:  This  study  investigated  the  innate  immune  response  in  septic  newborns.  Septic
newborns that  relied  almost  exclusively  on  the  innate  immune  system  showed  little  in  vivo
response  at  monocyte  activation,  suggesting  impaired  immune  response  and  increased  suscep-
tibility  to  infection.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
 Please cite this article as: Redondo AC, Ceccon ME, Silveira-Lessa AL, Quinello C, Palmeira P, Carvalho WB, et al. TLR-2 and TLR-4
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Expressão  do  TLR-2  e  do  TLR-4  em  monócitos  de  recém-nascidos  a  termo  com  sepse
tardia
Resumo
Objetivos:  Analisar  a  expressão  dos  TLR-2  e  TLR-4  em  monócitos  de  recém-nascidos  com  sepse
tardia.
Métodos: Trata-se  de  um  estudo  prospectivo  com  27  recém-nascidos  a  termo  entre  8  e  29  dias
de vida  com  diagnóstico  clínico  e  laboratorial  de  sepse  tardia  dos  quais  dez  (37%)  apresen-
taram cultura  positiva.  As  citocinas  foram  determinadas  por  teste  de  CBA  em  sangue  periférico
enquanto  que  a  expressão  e  MFI  (mediana  de  intensidade  de  ﬂuorescência)  dos  TLR-2  e  TLR-4
foi  determinado  por  imunofenotipagem  em  monócitos  de  sangue  periférico  total  através  de
análise  pelo  citômetro  de  ﬂuxo  BD  FACSDiva.  O  grupo  usado  para  comparac¸ão  foi  de  adultos
saudáveis.
Resultados:  Microrganismos  foram  identiﬁcados  em  37%  dos  pacientes  e  estes  juntamente  com
os  pacientes  com  sepse  clínica  tiveram  níveis  elevados  de  citocinas  pró-inﬂamatórias  (IL-8,  IL-6,
IL-1)  e  de  citocina  anti-inﬂamatória  (IL-10)  corroborando  o  processo  inﬂamatório/infeccioso.
No monócito,  a  frequência  de  expressão  do  TLR-4  foi  mais  elevada  (p  =  0,01).
Conclusões: Este  estudo  analisou  a  resposta  imune  inata  no  recém-nascido  com  sepse.  Recém-
nascidos sépticos  que  dependem  quase  exclusivamente  do  sistema  imune  inato  apresentaram
pouca  resposta  in  vivo  na  ativac¸ão  de  monócitos  o  que  sugere  uma  resposta  imune  deﬁciente  e
maior  susceptibilidade  à  infecc¸ão.
©  2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
E
t
T
t
t
t
p
r
i
d
a
(
i
i
p
i
d
i
a
i
p
g
d
t
t
i
a
Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Sepsis  represents  a  major  cause  of  morbidity  and  mortality  in
the newborn,1,2 whose  severity  is  proportional  to  the  inter-
action between  the  host  and  the  causative  agent,  triggering
a cascade  of  events  responsible  for  the  immune  response
expression.
Late-onset sepsis  occurs  after  72  hours  of  life,  with  clin-
ical signs  and  symptoms  that  may  be  subtle  and  nonspeciﬁc
early in  the  infection,  which  are  often  misinterpreted  or
mistaken for  other  non-infectious  clinical  conditions.  Nev-
ertheless,  its  evolution  can  be  fulminant,  leading  to  septic
shock, disseminated  intravascular  coagulation,  and  death
within hours.3--5
Differently  from  the  adult,  several  degrees  of  deﬁciency
have been  described  in  the  newborn  regarding  the  innate
and adaptive  immune  responses.6 At  birth,  the  adaptive
immune response  is  impaired,  both  by  the  minimal  in  utero
antigen exposure  and  by  B  and  T  effector  cell  dysfunction.1
Because  of  that,  the  newborn  relies  on  the  effectiveness  of
the innate  immune  response  and  the  passive  protection  of
maternal antibodies  acquired  transplacentally.7
A  primordial  part  of  the  innate  immune  response
trigger corresponds  to  the  activation  of  the  toll-like  recep-
tors (TLRs),  expressed  on  the  surface  of  monocytes,
macrophages,  dendritic  cells,  lymphocytes,  epithelial  cells,
or in  the  cytoplasm  of  different  tissue  cells.  Of  the  ten  types
of receptors  described  in  humans,  TLR-2  and  TLR-4  mainly
recognize components  of  Gram-positive  and  Gram-negative
bacteria, respectively.The  signal  transduction  activation  recruits  several  intra-
cellular proteins  (MyD88,  IRAK,  and  TRAF-6),  which  trigger
the activation  of  JNK  (Jun  amino-terminal  kinases)  and
T
T
lRK  (extracellular  signal-regulated  kinases)  pathways  in
he cascade  of  mitogen-activated  protein  kinases  (MAPKs).
his induces  the  activation  of  transcription  factors  activa-
or protein  1  (AP-1)  and  nuclear  factor  kappa  B  (NF-kB)
hat express  several  genes  directly  involved  in  the  produc-
ion of  inﬂammatory  cytokines  in  response  to  infection,
laying a key  role  in  the  ampliﬁcation  of  cell  immune
esponse.8--11
Monocytes  are  antigen-presenting  cells  that  act  on  the
nﬂammatory process  and  as  a  source  of  macrophages  and
endritic cells.  After  activation  through  TLRs,  there  is
n increase  in  the  expression  of  costimulatory  molecules
CD80 and  CD86),  which  are  important  in  the  early  adaptive
mmune response  and  cytokine  production.12
The  regulation  of  the  immune  system  at  birth  results
n a  biased  TLR  neonatal  response  by  stimulating  a  lower
roduction of  pro-inﬂammatory  cytokines  and  demonstrat-
ng lower  multi-functionality.13,14 Only  in  the  course  of  life
o cytokine  levels  become  equivalent  to  those  of  the  adult
ndividual.15 However,  in  the  neonatal  period,  quantitative
nd qualitative  changes  in  TLRs  and  cells  participating  in  the
nnate immune  response  have  been  described  when  com-
ared to  the  adult  individual,  which  are  proportional  to
estational age  at  birth.16 These  differences  could  eluci-
ate the  increased  susceptibility  to  infection  observed  in
he neonatal  age  group.1,17
Therefore,  despite  the  growing  awareness  of  the  impor-
ance of  the  TLR  system  in  protecting  newborns  against
nfections,18 much  still  needs  to  be  clariﬁed  about  the  mech-
nisms of  regulation  of  TLR  responses  in  the  neonatal  period.
hus, this  study  aimed  to  characterize  the  expression  of
LR-2 and  TLR-4  in  monocytes  of  full-term  newborns  with
ate-onset sepsis.
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ethods
his  was  a  prospective  study,  whose  convenience  sample
ncluded 27  full-term  newborns  transferred  to  the  neonatal
ntensive care  unit  (NICU)  of  the  Instituto  da  Crianc¸a-  Hos-
ital das  Clínicas  da  Faculdade  de  Medicina  da  Universidade
e São  Paulo  (HCFMUSP),  from  February  of  2011  to  January
f 2013.  Patients  whose  gestational  age  ranged  from  37  to
2 weeks  and  showed  clinical  and/or  laboratory  symptoms
complete blood  count  and  C-reactive  protein)  of  neonatal
epsis from  72  hours  up  to  30  days  of  life  at  the  time  of
dmission or  during  hospitalization,  which  led  to  the  start
f antibiotic  therapy,  were  included  in  the  study.
Exclusion  criteria  were  factors  that  alone  would  alter  the
mmune response,  such  as:  diagnosis  of  congenital  infec-
ions, inborn  errors  of  metabolism,  use  of  anti-inﬂammatory
rugs (indomethacin,  ibuprofen,  and  steroids),  diagnosis  of
ntracranial hemorrhage  conﬁrmed  by  skull  ultrasound  or
omputed tomography  and  surgery  in  the  week  before,  in
ddition to  those  in  which  the  date  of  sample  collection  did
ot permit  analysis.
The  criteria  used  to  deﬁne  and  classify  the  diagnosis
egarding clinical  severity  (sepsis,  severe  sepsis,  and  septic
hock) were  those  mentioned  in  the  Surviving  Sepsis  Cam-
aign (2012),  adjusted  for  age  range  based  on  the  criteria
f Goldstein  (2005)  as  determined  by  the  consensus.19,20
he  complete  blood  counts  (CBC)  analysis  was  based  on  the
ematologic Scoring  System  (HSS)  of  Rodwell,  whereas  CRP
C-reactive protein)  level  >  10  mg/L  was  considered  sug-
estive of  infection.  The  study  was  approved  by  the  Ethics
ommittee for  Analysis  of  Research  Projects  of  the  HCFMUSP
CAPPesq).
ampling
fter  an  informed  consent  was  obtained  from  the  legal
uardians of  the  newborn,  blood  samples  were  collected
y venipuncture  from  a  peripheral  vein  for  assessment  of
nfectious picture  (CBC,  CRP,  and  blood  culture)  and  anal-
sis of  cytokines  and  monocytes.  The  time  of  collection
as standardized  to  occur  within  the  ﬁrst  24  hours  from  the
uspected diagnosis  of  infection  and  the  start  of  antibiotic
herapy. An  aliquot  of  0.5  mL  of  blood  was  distributed  in
 separator  tube  with  gel  for  cytokine  measurement,  and
.5 mL  was  placed  in  a  tube  with  EDTA  (Ethylenediamine
f
T
a
t
Table  1  Monocyte  cell  surface  markers.
Monoclonal  antibody  Clone  
HLA-DR  L243  
CD14  M5E2  
CD80  BB1  
CD86  2331(FUN-1)  
TLR-2  (CD282)  11G7  
TLR-4  (CD284) HTA  125  
HLA-DR, human leukocyte antigen class II-DR locus; CD, cluster of differ
bined with cyanine dye; Paciﬁc blue, 6,8-diﬂuoro-7-hydroxycoumarin 
of phycoerythrin and cyanine dye; Alexa 647, ﬂuorochrome for reading
the speciﬁed markers of monoclonal antibodies.
a BioLegend Inc. (San Diego, CA, United States)Redondo  AC  et  al.
etraacetic  acid)  for  immunophenotyping,  which  were  both
erformed at  the  Laboratory  of  Medical  Investigation  36  (LIM
6) of  Instituto  da  Crianc¸a of  HCFMUSP.
ytokine  analysis
ytokines  TNF-  , IL-1  , IL-2,  IL-4,  IL-6,  IL-8,  and  IL-10
ere measured  in  serum  samples  using  a human  cytometric
ead array  (CBA)  set  (Cytometric  bead  array  BD  OptEIATM
et  Human,  Becton,  Dickinson  and  Company,  USA)  according
o the  manufacturer’s  instructions.
nalysis  of  TLRs
mmunophenotyping  was  performed  with  the  sample  red
lood cells,  which  were  collected  in  tubes  containing  EDTA
fter being  prepared  for  addition  of  pre-established  anti-
odies (Table  1)  and  processed  until  they  were  transferred
o be  read  in  the  ﬂow  cytometer  FACS  II  LRS  Fortessa  (Bec-
on, Dickinson  and  Company,  USA).  The  monocyte  population
as deﬁned  by  gating  of  CD14+HLA-DR+  cells  using  the  size
forward scatter  - FSC)  and  cell  granularity  as  parameters
side scatter  - SSC)  as  described  in  the  literature.20
The  analysis  was  performed  in  FlowJo  software  (Tree
tar -  Ashland,  OR,  United  States),  where  each  cell  popu-
ation was  analyzed  separately  by  gating  using  cell  size  and
ranularity as  parameters.  The  same  software  provided  data
epresenting the  median  ﬂuorescence  intensity  (MFI)  of  the
espective markers.
The  absolute  numbers  of  populations  were  calculated  by
ultiplying the  percentage  indicated  for  each  population
n ﬂow  cytometry  and  the  absolute  number  of  leukocytes
etermined by  automatic  cell  counter.
lood  control  samples  from  healthy  adults
eripheral  blood  samples  were  obtained  from  27  healthy
dults and  used  for  test  standardization  and  control.  The
election criteria  were:  healthy  adult  volunteers;  aged  18-
5 years;  of  both  genders;  with  negative  serological  tests
or human  immunodeﬁciency  virus  (HIV),  HTLV  I/II  (Human
 lymphotropic  virus  type  I/II),  hepatitis  B  and  C,  syphilis,
nd Chagas  disease;  and  no  symptoms  of  infection  during
he collection  period.
Fluorochrome  Manufacturer
APC  Cy7  BD  Biosciences
Paciﬁc  blue  BD  Biosciences
FITC  BD  Biosciences
PE  Cy5  BD  Biosciences
Alexa  647  BD  Biosciences
PE  BioLegenda
entiation; TLR, toll-like receptor; APC Cy7, allophycocyanin com-
ﬂuorophore; FITC, ﬂuorescein isothiocyanate; PE Cy5, conjugate
 between 594 and 633 nm; PE, R-phycoerythrin. Clone, refers to
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Table  2  Distribution  of  27  newborns  according  to  the  clinical  and  laboratory  data.
CLINICAL  DATA  (Median  [25th-75th percentile])
Age  at  admission  (days)  11  (2-22)
Age at  symptom  onset  (days)  20  (8-29)
Age at  collection  (days)  21  (12-30)
Weight  (g)  3,130  (2,823-3,511)
Gender (M:F)  1.07:  1
LABORATORY  ASSESSMENT  (Median  [25th-75th percentile])
- HSS 1  (0-3)
- CRP  (mg/L) 35.2  (9-83.1)
Cultures  (N  [%])
- Positive  cultures 10 (37%)
Gram-positive  bacteria  4  (40%)
Staphylococcus  epidermidis  3
Staphylococcus  aureus 1
Gram-negative bacteria 6 (60%)
Enterobacter  cloacae 1
Salmonella sp. 1
Escherichia  coli 2a
Klebsiella  pneumoniae 1
Bordetella  pertussis 1
- Negative  cultures 17 (63%)
CYTOKINES pg/mL
[Median (25th-75th percentile)]
Positive  culture  Negative  culture  p
-  IL-6  147.7  (72.2-385.1)  132.3  (6.3-332)  0.6066
-  IL-8  137.9  (61.1-411.8)  58.1  (16.3-55.4)  0.5414
-  IL-1  3.0  (1.07-15.8)  2.55  (1.15-5.62)  0.5349
-  IL-10 8.05  (4.12-19.9)  3.5  (1.8-76.15)  0.4516
-  TNF-    1.2  (0.45-1.7)  1.75  (1.0-2.47)  0.1188
-  IL-2 1.7  (1.4-1.9)  2.4  (1.6-4.55)  0.1014
-  IL-4 2.2  (0.85-2.8) 0.4  (0.3-1.1)  0.0714
ein; I
c
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wHSS, hematologic scoring system of Rodwell; CRP, C-reactive prot
a One patient with positive urine culture for Escherichia coli.
Statistical  analysis
The  newborn  data  were  recorded  on  the  collection  forms  and
stored in  spreadsheets  from  the  statistical  package  Graph-
Pad Prism®,  release  6.0c  for  Mac  OSX  (GraphPad  Software,
La Jolla  California,  United  States).  For  qualitative  variables,
absolute and  relative  frequencies  (percentage  and  number
of cases)  were  calculated,  whereas  for  quantitative  varia-
bles, the  median,  the  minimum  and  maximum  values,  and
interquartile range  (P25-P75)  were  calculated  for  each  of
the receptors  evaluated  in  each  analysis.  The  Mann-Whitney
test was  used  to  compare  the  median  of  markers  between
the groups,  while  the  comparative  analysis  of  the  medi-
ans of  more  than  two  groups  used  the  Kruskal-Wallis  test
with Dunn’s  post-test.  The  tests  were  performed  with  95%
conﬁdence intervals  and  a  p-value  <  0.05  was  considered
signiﬁcant.
ResultsClinical  and  laboratory  characteristics  of  the  27  infants
included in  the  study  are  shown  in  Table  2.  It  can
be observed  that  most  patients  (62.9%)  had  symptoms
f
a
tL, interleukin; TNF-, tumor necrosis factor alpha.
ompatible  with  severe  sepsis  (44.4%)  and  septic  shock
18.5%), which  occurred  at  a  median  age  of  20  days  of  life;
eath was  observed  in  only  two  patients  (7.4%).  Among  the
7 patients  who  had  negative  cultures,  all  showed  clear
linical signs  and  symptoms  of  infection  and  compatible  lab-
ratory alterations  in  the  CBC  and  CRP  levels  at  diagnosis
nd subsequent  clinical  analysis,  and  thus  were  considered
atients with  clinical  sepsis.
Of  these  patients  with  clinical  sepsis,  eight  (47%)  had
 clinical  picture  compatible  with  sepsis,  ﬁve  (29.5%)  with
evere sepsis,  and  four  (23.5%)  with  septic  shock.  Moreover,
he measurement  of  pro-inﬂammatory  cytokines  was  simi-
ar in  infected  patients  regardless  of  positive  cultures,  as
hown in  Table  2.  Culture  positivity  in  material  collected
rom sterile  ﬂuids  (blood,  urine,  and  CSF)  occurred  in  ten
atients (37%),  with  distribution  according  to  the  isolated
gent as  shown  in  the  same  table.
Regarding  monocytes,  it  can  be  observed  that  despite  the
act that  their  total  absolute  number  was  higher  in  newborns
hen compared  to  adults  (p  <  0.0001),  there  was  a  similar
requency of  monocytes  between  groups  (Fig.  1).
MFI  for  activation  molecules  CD80,  CD86;  and  frequency
nd MFI  for  TLR-2  and  TLR-4  are  shown  in  Fig.  1.  In  addition
o a  lower  MFI  for  CD86  in  newborns  with  infection,  these
476  Redondo  AC  et  al.
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Figure  1  Box  plot  of  absolute  numbers  (cells/L),  frequency  (%),  and  median  ﬂuorescence  intensity  (MFI)  of  CD80,  CD86,  TLR-2,
and  TLR-4  activation  molecules.  Values  expressed  as  median  ±  interquartile  range  (P25-P75);  p  refers  to  statistical  signiﬁcance.
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Dample  number  of  the  ‘‘newborn’’  and  ‘‘adult’’  groups  =  27.
B, newborn;  HLA-DR,  human  leukocyte  antigen  class  II-DR  locu
atients  showed  maintenance  of  CD80  and  TLR-2  expres-
ion (p  =  0.822  and  p  =  0.825,  respectively),  while  there
as a  higher  frequency  for  TLR-4  in  septic  newborns  when
ompared to  adults  (p  =  0.0043).
Culture  positivity  was  associated  to  a  higher  frequency
f TLR-4  when  compared  to  adults  and  patients  with  nega-
ive cultures  (Table  3),  while  there  was  a  similar  frequency
etween groups  in  the  evaluation  of  TLR-2.
Despite  the  identiﬁcation  of  some  bacteria,  the  analysis
etween culture  positivity  according  to  the  type  of  bacteria
T
e
p
tD,  cluster  of  differentiation;  TLR,  toll-like  receptor.
dentiﬁed  and  the  types  of  TLR  was  not  performed  due  to
he sample  number.
iscussionhis  study  described  the  in  vivo  response  of  neonatal  periph-
ral blood  monocytes  in  the  presence  of  an  infectious
icture, which  showed  similar  or  lower  expression  of  activa-
ion molecules,  in  addition  to  increased  expression  of  TLR-4
Immune  response  in  late-onset  sepsis  477
Table  3  Median  frequency  (%)  and  MFI  of  toll-like  receptors  2  and  4  in  peripheral  blood  monocytes  of  infected  newborns
(positive  or  negative  culture),  and  adult  peripheral  blood.
Monocytes  Adult  Negative  Culture  Positive  Culture  p
[N] Median  (25th-75th percentile)
%
TLR-2  [27]  93.5
(82-98.5)
[17]  96.5
(82.2-97.6)
[10]  87.1
(59-92.2)
0.475
TLR-4 [27]  10.6
(5.7-17.9)
[17]  11.8
(6.7-24.9)
[10]  30.5
(18.5-72.1)
0.0011
MFI
TLR-2 [27]  3,134
(1,336-6,386)
[17]  8,631
(2,972-15,300)
[10]  5,504
(3,921-42,850)
0.516
TLR-4 [27]  2,768
(2,159-4,377)
[17]  4,276
(1,594-5,088)
[10]  3,204
(2,017-3,831)
0.867
p refers to statistical signiﬁcance using the Kruskal-Wallis test.
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ReferencesMFI,  median ﬂuorescence intensity; TLR, toll-like receptor.
in  newborns  with  infection  caused  by  Gram-positive  and
Gram-negative bacteria,  and  increased  expression  of  TLR-2
in patients  with  clinical  sepsis.
Monocytes  are  phagocytic  cells,  and  play  an  important
role in  innate  and  acquired  immunity  through  their  effects
on the  inﬂammatory  process  or  as  a  source  of  macrophages
and dendritic  cells.  The  behavior  of  TLRs  in  the  new-
born, either  in  healthy  or  infected  infants,  is  controversial.
According to  Levy  et  al.,  although  the  basal  expression  of
TLRs in  monocytes  of  full-term  newborns  is  similar  to  that  of
adult individuals,  the  functional  consequences  of  activation
are quite  different,  as  a  lower  production  of  cytokines  and
lower expression  of  co-stimulatory  molecules  are  observed
in newborns.18
It  was  observed  that  in  the  presence  of  an  infectious  stim-
ulus, the  population  of  assessed  newborns  showed  a  lower
number of  activated  cells  (lower  MFI  for  CD86  than  in  the
adult individual  and  MFI  for  CD80  similar  to  adult  individuals
without infection)  in  peripheral  blood,  suggesting  a  lower
activity potential  of  this  cell  type  in  newborns,  which  is  in
accordance with  the  literature.18--21
Regarding  TLR-2,  it  was  observed  that  it  was  widely
expressed in  neonatal  monocytes  (93.9%)  and  monocytes
of adult  individuals  without  infection  (94.6%).  The  same
similarity was  observed  regarding  MFI  for  this  receptor
(MFI =  4,748  and  6,386,  respectively)  regardless  of  culture
positivity, contradicting  ﬁndings  in  the  literature  that
demonstrate an  up-regulation  in  the  expression  of  TLR-2
in monocytes  isolated  from  patients  with  sepsis,  as  well
as signiﬁcant  changes  in  TLR-2  expression.22,23 Thus,  in  the
present study,  in  which  all  newborns  had  clinical  and  labora-
tory signs  of  infection,  it  was  observed  that  despite  presence
of the  necessary  tools  to  recognize  the  invading  antigen
(TLR and  co-stimulatory  molecules),  they  did  not  undergo
the up-regulation  expected  in  the  overall  analysis.
Meanwhile,  contrary  to  what  was  reported  by  Viemann
et al.,1 the  presence  of  a  positive  culture  was  associated
with a  higher  frequency  in  TLR-4  expression  in  relation  to  the
adult individual  with  a  negative  culture,  probably  secondary
to the  fact  that  most  patients  with  positive  cultures  had
Gram-negative bacteria  (60%)  isolated  from  the  culture.  Asor  the  similar  expression  of  the  same  receptor  in  newborns
ith negative  cultures  and  in  adult  patients,  it  may  sug-
est a  tendency  to  immunoparalysis  that  would  have  shifted
he median  to  lower  levels,  similar  to  the  levels  found  in
ealthy adult  individuals,  as  four  newborns  from  this  group
rogressed to  septic  shock.
The  present  study  has  limitations  that  should  be
mphasized, such  as  the  sample  size  and  the  pointwise  char-
cteristic of  the  infectious  picture  assessment.  However,  the
esults still  suggest  that  at  the  time  of  diagnostic  hypothe-
is of  infection  in  the  newborns,  TLR-2  and  TLR-4  receptors
ad a  higher  expression  in  infants  with  infection,  but  with
aintenance of  expression  of  costimulatory  molecules,  indi-
ating  a  possible  deﬁciency  in  the  cell  activation  process
n vivo.
Thus, although  larger  extrapolations  cannot  be  made,  the
uthors believe  it  would  be  intriguing  to  assess  the  response
f TLR  as  well  as  that  of  cell  activation  in  newborns  during
he evolution  of  a  clinical  infection.
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